health canada approval zepbound tirzepatide obesity canada date (Tirzepatide) | Uses & Price Canadian residents only | Zepbound™

28:07 Dr

It is made of a short head and a long head which function together

Our physician-led approach prioritizes your safety and long-term success with programs tailored to your bodys unique needs

It participates in the synthesis of adenosine triphosphate (ATP) a molecule that stores and transports energy within cells

Tirzepatide was FDA-approved for the treatment of type 2 diabetes under the brand name Mounjaro in 2022, and subsequently FDA-approved for chronic weight management under the brand name Zepbound in 2023 following the landmark SURMOUNT clinical trial program, which demonstrated average weight reductions of 20.9% of body weight at the highest dose over 72 weeks of treatment